<List><item><source>MED</source><extId>29307081</extId><pmcid>PMC6061181</pmcid><annotations><annotation><prefix>cial sphere in autistic individuals [</prefix><exact>NCT02627508</exact><postfix>]. </postfix><tags><tag><name>NCT02627508</name><uri>http://identifiers.org/clinicaltrials/NCT02627508</uri></tag></tags><id>http://europepmc.org/articles/PMC6061181#europepmc-74db5d910eb0fe1d143ca91d28020fb8</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>s with risperidone [</prefix><exact>NCT01171937</exact><postfix>, NCT00576732, NCT01</postfix><tags><tag><name>NCT01171937</name><uri>http://identifiers.org/clinicaltrials/NCT01171937</uri></tag></tags><id>http://europepmc.org/articles/PMC6061181#europepmc-ea6ebc467a5f7fa3e8534f3ae6afe679</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>idone [NCT01171937, </prefix><exact>NCT00576732</exact><postfix>, NCT01333072, NCT00</postfix><tags><tag><name>NCT00576732</name><uri>http://identifiers.org/clinicaltrials/NCT00576732</uri></tag></tags><id>http://europepmc.org/articles/PMC6061181#europepmc-c39c8ce2149035c3f9dbb58435d90062</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>71937, NCT00576732, </prefix><exact>NCT01333072</exact><postfix>, NCT00080145, NCT00</postfix><tags><tag><name>NCT01333072</name><uri>http://identifiers.org/clinicaltrials/NCT01333072</uri></tag></tags><id>http://europepmc.org/articles/PMC6061181#europepmc-2ef3d06a0e81ed338f2fa58252d04205</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>76732, NCT01333072, </prefix><exact>NCT00080145</exact><postfix>, NCT00584701, NCT00</postfix><tags><tag><name>NCT00080145</name><uri>http://identifiers.org/clinicaltrials/NCT00080145</uri></tag></tags><id>http://europepmc.org/articles/PMC6061181#europepmc-652551fd8655c8e9c8b9938a4af4e4b0</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>33072, NCT00080145, </prefix><exact>NCT00584701</exact><postfix>, NCT00005014, NCT01</postfix><tags><tag><name>NCT00584701</name><uri>http://identifiers.org/clinicaltrials/NCT00584701</uri></tag></tags><id>http://europepmc.org/articles/PMC6061181#europepmc-caf453b713651739775197182ddcf5fb</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>80145, NCT00584701, </prefix><exact>NCT00005014</exact><postfix>, NCT01624675, NCT00</postfix><tags><tag><name>NCT00005014</name><uri>http://identifiers.org/clinicaltrials/NCT00005014</uri></tag></tags><id>http://europepmc.org/articles/PMC6061181#europepmc-9d999117f6c76b833d5840d8ed7ceba4</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>84701, NCT00005014, </prefix><exact>NCT01624675</exact><postfix>, NCT00086645, NCT00</postfix><tags><tag><name>NCT01624675</name><uri>http://identifiers.org/clinicaltrials/NCT01624675</uri></tag></tags><id>http://europepmc.org/articles/PMC6061181#europepmc-9e023861b47be4f129799d4aa74ff465</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>05014, NCT01624675, </prefix><exact>NCT00086645</exact><postfix>, NCT00374764, NCT00</postfix><tags><tag><name>NCT00086645</name><uri>http://identifiers.org/clinicaltrials/NCT00086645</uri></tag></tags><id>http://europepmc.org/articles/PMC6061181#europepmc-42322127b6047ca9fc2d2e8d31d1727d</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>24675, NCT00086645, </prefix><exact>NCT00374764</exact><postfix>, NCT00166595, NCT00</postfix><tags><tag><name>NCT00374764</name><uri>http://identifiers.org/clinicaltrials/NCT00374764</uri></tag></tags><id>http://europepmc.org/articles/PMC6061181#europepmc-46ec05eaaed476e19e9d62b42e537858</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>86645, NCT00374764, </prefix><exact>NCT00166595</exact><postfix>, NCT0014739] and ar</postfix><tags><tag><name>NCT00166595</name><uri>http://identifiers.org/clinicaltrials/NCT00166595</uri></tag></tags><id>http://europepmc.org/articles/PMC6061181#europepmc-b2837ddff97f68d185d5f51c77ed54b5</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>] and aripiprazole [</prefix><exact>NCT00619190</exact><postfix>, NCT01333072, NCT00</postfix><tags><tag><name>NCT00619190</name><uri>http://identifiers.org/clinicaltrials/NCT00619190</uri></tag></tags><id>http://europepmc.org/articles/PMC6061181#europepmc-7573358263760665e4d2177026f77b8f</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>azole [NCT00619190, </prefix><exact>NCT01333072</exact><postfix>, NCT00468130 NCT002</postfix><tags><tag><name>NCT01333072</name><uri>http://identifiers.org/clinicaltrials/NCT01333072</uri></tag></tags><id>http://europepmc.org/articles/PMC6061181#europepmc-43153a57e31a08d9467079844d361bf6</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>19190, NCT01333072, </prefix><exact>NCT00468130</exact><postfix> NCT00208533 NCT0019</postfix><tags><tag><name>NCT00468130</name><uri>http://identifiers.org/clinicaltrials/NCT00468130</uri></tag></tags><id>http://europepmc.org/articles/PMC6061181#europepmc-62c3b4af5038fba00d705683f5bf098d</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>333072, NCT00468130 </prefix><exact>NCT00208533</exact><postfix> NCT00198107, NCT010</postfix><tags><tag><name>NCT00208533</name><uri>http://identifiers.org/clinicaltrials/NCT00208533</uri></tag></tags><id>http://europepmc.org/articles/PMC6061181#europepmc-5e8ff8a638cb16123c70df9562937b94</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>0468130 NCT00208533 </prefix><exact>NCT00198107</exact><postfix>, NCT01028820, NCT01</postfix><tags><tag><name>NCT00198107</name><uri>http://identifiers.org/clinicaltrials/NCT00198107</uri></tag></tags><id>http://europepmc.org/articles/PMC6061181#europepmc-ff82e2c816f19981c85c960cef4fe590</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>208533 NCT00198107, </prefix><exact>NCT01028820</exact><postfix>, NCT01617447, NCT00</postfix><tags><tag><name>NCT01028820</name><uri>http://identifiers.org/clinicaltrials/NCT01028820</uri></tag></tags><id>http://europepmc.org/articles/PMC6061181#europepmc-0d320821e1302f4592f759757c69e7e6</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>98107, NCT01028820, </prefix><exact>NCT01617447</exact><postfix>, NCT00332241, NCT00</postfix><tags><tag><name>NCT01617447</name><uri>http://identifiers.org/clinicaltrials/NCT01617447</uri></tag></tags><id>http://europepmc.org/articles/PMC6061181#europepmc-84be88110284d348a2b921d8e29a9d13</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>28820, NCT01617447, </prefix><exact>NCT00332241</exact><postfix>, NCT00308074, NCT01</postfix><tags><tag><name>NCT00332241</name><uri>http://identifiers.org/clinicaltrials/NCT00332241</uri></tag></tags><id>http://europepmc.org/articles/PMC6061181#europepmc-6849b11eea0e866e30d10ed1b9d5df98</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>17447, NCT00332241, </prefix><exact>NCT00308074</exact><postfix>, NCT01227668, NCT01</postfix><tags><tag><name>NCT00308074</name><uri>http://identifiers.org/clinicaltrials/NCT00308074</uri></tag></tags><id>http://europepmc.org/articles/PMC6061181#europepmc-ee6ce4c43a07d32e3bac5d2375baff7a</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>32241, NCT00308074, </prefix><exact>NCT01227668</exact><postfix>, NCT01617460, NCT00</postfix><tags><tag><name>NCT01227668</name><uri>http://identifiers.org/clinicaltrials/NCT01227668</uri></tag></tags><id>http://europepmc.org/articles/PMC6061181#europepmc-65ce5fd6becc8b805b07113da9268ab2</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>08074, NCT01227668, </prefix><exact>NCT01617460</exact><postfix>, NCT00337571, NCT00</postfix><tags><tag><name>NCT01617460</name><uri>http://identifiers.org/clinicaltrials/NCT01617460</uri></tag></tags><id>http://europepmc.org/articles/PMC6061181#europepmc-11c06ff213f885236222c294fbba18de</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>27668, NCT01617460, </prefix><exact>NCT00337571</exact><postfix>, NCT00365859, NCT00</postfix><tags><tag><name>NCT00337571</name><uri>http://identifiers.org/clinicaltrials/NCT00337571</uri></tag></tags><id>http://europepmc.org/articles/PMC6061181#europepmc-fb81106164d5e74d64f4f85c516504e3</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>17460, NCT00337571, </prefix><exact>NCT00365859</exact><postfix>, NCT00198055, NCT00</postfix><tags><tag><name>NCT00365859</name><uri>http://identifiers.org/clinicaltrials/NCT00365859</uri></tag></tags><id>http://europepmc.org/articles/PMC6061181#europepmc-25c7ec26f608f11c21055b4779bb6c1c</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>37571, NCT00365859, </prefix><exact>NCT00198055</exact><postfix>, NCT00870727] were </postfix><tags><tag><name>NCT00198055</name><uri>http://identifiers.org/clinicaltrials/NCT00198055</uri></tag></tags><id>http://europepmc.org/articles/PMC6061181#europepmc-1a5be56122a7d27802c4f32c48d6ee09</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>0365859, NCT00198055, </prefix><exact>NCT00870727</exact><postfix>] were conducted. </postfix><tags><tag><name>NCT00870727</name><uri>http://identifiers.org/clinicaltrials/NCT00870727</uri></tag></tags><id>http://europepmc.org/articles/PMC6061181#europepmc-c464682e5c41d79d8b6ae4fef8258bf5</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix> acetyl-choline esterase inhibitors [</prefix><exact>NCT01098383</exact><postfix>]. </postfix><tags><tag><name>NCT01098383</name><uri>http://identifiers.org/clinicaltrials/NCT01098383</uri></tag></tags><id>http://europepmc.org/articles/PMC6061181#europepmc-d5b89e9bf24872e04f4fd955aaf2a937</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix> by PET imagining is currently open [</prefix><exact>NCT03117530</exact><postfix>]. </postfix><tags><tag><name>NCT03117530</name><uri>http://identifiers.org/clinicaltrials/NCT03117530</uri></tag></tags><id>http://europepmc.org/articles/PMC6061181#europepmc-bceed7353fe17734fe40a00c580cf689</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation></annotations></item></List>